Suprathel® or Mepilex® Ag for treatment of partial thickness burns in children: A case control study

Burns. 2023 Nov;49(7):1585-1591. doi: 10.1016/j.burns.2023.03.003. Epub 2023 Mar 11.

Abstract

Aim: The study aim was to investigate if Suprathel® can be an adequate alternative to Mepilex® Ag for the treatment of partial-thickness scalds in children.

Methods: A retrospective study including 58 children admitted to The Burn Centre in Linköping, Sweden between year 2015 and 2022. Of the 58 children, 30 were dressed with Suprathel ® and 28 with Mepilex ® Ag. Outcomes investigated were healing time, burn wound infection (BWI), need for operations and number of dressing changes.

Results: We found no significant differences in any of the outcomes. In the Suprathel ® group 17 children and in the Mepilex ® Ag group 15 children were healed within 14 days. Ten children from each group received antibiotics for suspected BWI and two from each group underwent an operation with skin grafting. Each group had on median four dressing changes.

Conclusions: Two different treatments were compared for children with partial-thickness scalds, and the data indicates that similar results are received with both dressings.

Keywords: Children; Healing; Partial thickness burns; Scalds; Wound dressings.

MeSH terms

  • Burns* / therapy
  • Case-Control Studies
  • Child
  • Humans
  • Retrospective Studies
  • Surgical Wound Infection
  • Wound Healing

Substances

  • poly(lactide-co-trimethylenecarbonate-co-epsilon-caprolactone)